Basic Information
MEBIAS: An Emerging Leader in Pathway-Selective G Protein-Coupled Receptor (GPCR) Drug Discovery
Mebias Discovery
Philadelphia,Pennsylvania,United States of America
less than 15 people
January 01, 2016
protein.dynamics@mebiasdiscovery.com